Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 17621 - 17640 out of 566296 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (L01FA01) rituximab | Ruxience 100 mg/10 mL injection, 10 mL vial | Solution for I.V. infusion 100 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell;Arthritis, Rheumatoid;Microscopic Polyangiitis;Pemphigus | PfizerAustraliaPtyLtd |
| Australia | (L01FA01) rituximab | Truxima 100 mg/10 mL injection, 2 x 10 mL vials | Solution for I.V. infusion 100 mg in 10 mL, 2 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Arthritis, Rheumatoid;Wegener Granulomatosis;Leukemia, Lymphocytic, Chronic, B-Cell;Microscopic Polyangiitis | CelltrionHealthcareAustraliaPtyLtd |
| Australia | (L01FA01) rituximab | Truxima 100 mg/10 mL injection, 2 x 10 mL vials | Solution for I.V. infusion 100 mg in 10 mL, 2 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Arthritis, Rheumatoid;Wegener Granulomatosis;Leukemia, Lymphocytic, Chronic, B-Cell;Microscopic Polyangiitis | CelltrionHealthcareAustraliaPtyLtd |
| Australia | (L01FA01) rituximab | Riximyo 500 mg/50 mL injection, 50 mL vial | Solution for I.V. infusion 500 mg in 50 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Arthritis, Rheumatoid;Microscopic Polyangiitis;Wegener Granulomatosis | SandozPtyLtd |
| Australia | (L01FA01) rituximab | Riximyo 500 mg/50 mL injection, 50 mL vial | Solution for I.V. infusion 500 mg in 50 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Arthritis, Rheumatoid;Microscopic Polyangiitis;Wegener Granulomatosis | SandozPtyLtd |
| Australia | (L01FA01) rituximab | Ruxience 500 mg/50 mL injection, 50 mL vial | Solution for I.V. infusion 500 mg in 50 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell;Arthritis, Rheumatoid;Microscopic Polyangiitis;Pemphigus | PfizerAustraliaPtyLtd |
| Australia | (L01FA01) rituximab | Ruxience 500 mg/50 mL injection, 50 mL vial | Solution for I.V. infusion 500 mg in 50 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell;Arthritis, Rheumatoid;Microscopic Polyangiitis;Pemphigus | PfizerAustraliaPtyLtd |
| Australia | (L01FA01) rituximab | Truxima 500 mg/50 mL injection, 50 mL vial | Solution for I.V. infusion 500 mg in 50 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Arthritis, Rheumatoid;Wegener Granulomatosis;Leukemia, Lymphocytic, Chronic, B-Cell;Microscopic Polyangiitis | CelltrionHealthcareAustraliaPtyLtd |
| Australia | (L01FA01) rituximab | Truxima 500 mg/50 mL injection, 50 mL vial | Solution for I.V. infusion 500 mg in 50 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Arthritis, Rheumatoid;Wegener Granulomatosis;Leukemia, Lymphocytic, Chronic, B-Cell;Microscopic Polyangiitis | CelltrionHealthcareAustraliaPtyLtd |
| Australia | (L01FA03) obinutuzumab (adm: P) | Gazyva 1 g/40 mL injection, 40 mL vial | Solution for I.V. infusion 1000 mg in 40 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | RocheProductsPtyLtd |
| Australia | (L01FA03) obinutuzumab (adm: P) | Gazyva 1 g/40 mL injection, 40 mL vial | Solution for I.V. infusion 1000 mg in 40 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | RocheProductsPtyLtd |
| Australia | (L01FA03) obinutuzumab (adm: P) | Gazyva 1 g/40 mL injection, 40 mL vial | Solution for I.V. infusion 1000 mg in 40 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | RocheProductsPtyLtd |
| Australia | (L01FA03) obinutuzumab (adm: P) | Gazyva 1 g/40 mL injection, 40 mL vial | Solution for I.V. infusion 1000 mg in 40 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | RocheProductsPtyLtd |
| Australia | (L01FA03) obinutuzumab (adm: P) | Gazyva 1 g/40 mL injection, 40 mL vial | Solution for I.V. infusion 1000 mg in 40 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | RocheProductsPtyLtd |
| Australia | (L01FA03) obinutuzumab (adm: P) | Gazyva 1 g/40 mL injection, 40 mL vial | Solution for I.V. infusion 1000 mg in 40 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | RocheProductsPtyLtd |
| Australia | (L01FA03) obinutuzumab (adm: P) | Gazyva 1 g/40 mL injection, 40 mL vial | Solution for I.V. infusion 1000 mg in 40 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | RocheProductsPtyLtd |
| Australia | (L01FA03) obinutuzumab (adm: P) | Gazyva 1 g/40 mL injection, 40 mL vial | Solution for I.V. infusion 1000 mg in 40 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | RocheProductsPtyLtd |
| Australia | (L01FB01) inotuzumab ozogamicin | Besponsa 1 mg powder for injection, 1 vial | Powder for I.V. infusion 1 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | PfizerAustraliaPtyLtd |
| Australia | (L01FB01) inotuzumab ozogamicin | Besponsa 1 mg powder for injection, 1 vial | Powder for I.V. infusion 1 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | PfizerAustraliaPtyLtd |
| Australia | (L01FC01) daratumumab (adm: P) | Darzalex 100 mg/5 mL injection, 5 mL vial | Solution concentrate for I.V. infusion 100 mg in 5 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
Pages
